CM Life Sciences, Inc. Profile Avatar - Palmy Investing

CM Life Sciences, Inc.

CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

Shell Companies
US, New York [HQ]

Balance Sheet

2 Sheets · Starting from 2020
In Million USD. Margins, Growth Rates In %
Metric 2020 None
Assets
444.00 - -
Current
1.00 - -
Non Current
442.00 - -
Liabilities
15.00 - -
Current
- - - -
Non Current
15.00 - -
Equity
428.00 - -
Stockholders' Equity
428.00 - -
Retained Earnings
- - - -
Common Stock
423.00 - -
Preferred Stock
- - - -
Profit
- - - -
Dividends
- - - -
Minority Interest
- - - -
Other Stockholders' Equity
5.00 - -
Loss Other Compr. Income
- - - -
End of CMLFU's Analysis
CIK: 1818331 CUSIP: - ISIN: US18978W2089 LEI: - UEI: -
Secondary Listings
CMLFU has no secondary listings inside our databases.